kabutan

ADR120S,Inc.(3750) Summary

3750
TSE Standard
ADR120S,Inc.
870
JPY
+3
(+0.35%)
Jan 29, 3:30 pm JST
5.68
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
109.4
PBR
27.1
Yield
ー%
Margin Trading Ratio
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
871 JPY 5.68 USD
Previous Close Jan 28
867 JPY 5.68 USD
High Jan 29, 9:00 am
871 JPY 5.68 USD
Low Jan 29, 11:27 am
867 JPY 5.65 USD
Volume
1,000
Trading Value
1.00M JPY 5.69K USD
VWAP
869.6 JPY 5.69 USD
Minimum Trading Value
87,000 JPY 568 USD
Market Cap
7.77B JPY 0.05B USD
Number of Trades
6
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Slightly Low
1-Year Average
42
1-Year High Apr 2, 2025
1,257
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 0 1,952,400
Jan 16, 2026 0 1,952,500
Jan 9, 2026 0 1,953,900
Dec 26, 2025 0 1,955,600
Dec 19, 2025 0 1,954,900
Company Profile
Cytori Cell Research Institute, Inc. has shifted its focus to regenerative medicine, medical devices, and medical tourism as its main business areas. The company is withdrawing from real estate and hotel operations.
Sector
Information & Communication
Cytori Cell Research Institute, Inc. is developing a medical business that invests in medical assets. The company sells medical devices such as Celution centrifuges and cell therapy kits to domestic medical institutions and university hospitals. In 2022, the company obtained domestic manufacturing and sales approval for the Celution Cell Therapy Kit, a highly controlled medical device, as a treatment for male stress urinary incontinence. Cytori Cell Research Institute, Inc. is withdrawing from real estate and hotel businesses, concentrating its management resources on the medical field.